Biolojic Design
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 Faneuil Hall Market Pl Fl 3, Boston, M...Website
www.biolojic.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Biolojic Design
Biolojic Design is pioneering advancements in antibody technology, focusing on the engineering of epitope-specific antibodies and multibodies to address challenges in treating autoimmune diseases and cancers. Utilizing machine learning, they create programmable antibodies that act as dynamic functional switches, enhancing drug efficacy while minimizing toxicity. Their pipeline emphasizes computationally designed antibodies targeting validated biological pathways in autoimmune diseases and immuno-oncology. The company aims to redefine drug design through a multidisciplinary team that integrates biology, AI, and drug development.Explore more
Biolojic Design Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biolojic Design your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Biolojic Design is spiking on competitors!
Check if Biolojic Design has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Biolojic Design had a recent Job posting/layoffs
Earning: See what the market has to say on Biolojic Design recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Biolojic Design
Funding: Get notified immidiatlly once Biolojic Design has new funding data
Biolojic Design, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Biolojic Design launches new products
Recommended Actions
Reach out to Masked Content who joined Biolojic Design as Masked Content
Find 2 more new buyers
Compare Similar Companies to Biolojic Design
Compare insights from companies similar to Biolojic Design, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$114.2M
51-200
Public
$462.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Company Profile Activity
Activity Insights
Biolojic Design is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biolojic Design is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biolojic Design.
Biolojic Design Tech Stack
A closer look at the technologies used by Biolojic Design
Most Recent Scoops
Project
, according to a high-level source in information technology, has completed initiatives related to continuous deployment within the last twelve months.
Implementation, Product Development, DevOps, Automation, Software, Information Technology
Project
, according to a high-level source in information technology, is currently in the request for proposal (RFP) stage for upcoming initiatives related to enterprise application integration (EAI).
Integration, Request for Proposal (RFP), Enterprise Software, Software, Enterprise Resource Planning, Information Technology
Project
, according to a high-level source in information technology, is planning upcoming initiatives related to network provisioning.
Network, Information Security, Infrastructure, Product Security, Enterprise Architecture, Cyber Security, Operating Systems, Security, Information Technology
Project
, according to a high-level source in information technology, is in the midst of initiatives related to document management systems.
Document Management, Software, Information Technology
Project
Spending/Investment, Engineering, Financial Planning, Funding, Product Management, Finance, Information Technology
Biolojic Design News & Media
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)
– TEV ‘325, which targets IL-13 and TSLP, is being studied for the treatment of TH2-driven inflammatory diseases such as asthma and atopic dermatitisBiolojic Design Appoints Roger Waltzman as Chief Medical Officer
Biolojic Design Appoints Roger Waltzman as new Chief Medical OfficerTeva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
REHOVOT, Israel and WASHINGTON and TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) and Biolojic Design Ltd. (“Biolojic”), a biotechnology company using computational biology and artificial intelligence to design next generation, multifunctional antibodies known as multibodies, announced today that Teva initiated IND-enabling studies with BD9, a dual-specific multibody targeting both TSLP (Thymic stromal lymphopoietin) and IL-13. Teva hBiolojic Design Appoints Neal Curran as Chief Business Officer
Biolojic Design announced the appointment of Neal Curran as Chief Business Officer.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biolojic Design
Sign Up For FreeTo access detailed company insights
Biolojic Design is pioneering advancements in antibody technology, focusing on the engineering of epitope-specific antibodies and multibodies to address challenges in treating autoimmune diseases and cancers. Utilizing machine learning, they create programmable antibodies that act as dynamic functional switches, enhancing drug efficacy while minimi... Read More
